Treatment of Clinically Important Bacteria With Cold Atmospheric Plasma

利用冷大气等离子体治疗临床重要细菌

阅读:1

Abstract

Antimicrobial resistance (AMR), especially in clinically important bacteria, has posed serious challenges to clinical treatments. Novel and effective antimicrobial strategies are urgently needed to address AMR. Cold atmospheric plasma (CAP) is a new concept of disinfection method that kills bacteria through various active species and particles within an ionised and electrical-balanced gas. In this review, we introduced the generation of CAP and summarised its disinfection mechanisms. Moreover, we reviewed the applications of CAP in treating globally important bacteria, including Gram-positive bacteria such as Staphylococcus aureus, Enterococcus spp., Streptococcus pyogenes and Mycobacterium tuberculosis, as well as Gram-negative bacteria including Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Acinetobacter baumannii and Neisseria gonorrhoeae. Additionally, we discussed technological strategies to enhance CAP disinfection efficacy and evaluated the safety of CAP applications. We recommend CAP as an effective alternative technology for combating bacterial infections and hope that the comprehensive information provided in the present review will facilitate the development of CAP-based disinfection strategies to overcome AMR issues in the future.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。